ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q4 2023
InvestorPlaceInvestorPlace – Stock Market News, Stock Advice & Trading Tips
ADAP stock results show that Adaptimmune Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
The post ADAP Stock Earnings:…